Delivery Order SPE2DB22D2206-SPE2DB25FEE32
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of CATHFLO ACTIVASE 2 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The $4,291.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 13, 2024, with a completion date of November 14, 2024. The contract is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,545.12 firm fixed-price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical pharmaceutical product. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Cathflo Activase 2 mg vials, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $7,313.27 and an ultimate completion date of May 1, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $1,336.82 for the supply of CATHFLO ACTIVASE 2 MG VIALS. The award has an ultimate completion date of June 5, 2024. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,063.79 firm fixed-price delivery order is for the supply of 2 mg vials of the medication Cathflo Activase. The contract has an ultimate completion date of November 18, 2024 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,635.80 Firm Fixed Price Delivery Order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a specialty medication. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,670.36, is a delivery order for the supply of 4564750980 CATHFLO ACTIVASE 2 MG VIALS, with a period of performance through May 31, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Activase (alteplase) 50 mg vials to the Defense Logistics Agency (DLA). The $22,886.54 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 5, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564628857 CATHFLO ACTIVASE 2 MG VIALS medical supplies. The contract, which is a Firm Fixed Price Delivery Order with a ceiling value of $10,028.43, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The award has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
This federal contract award is for medical supplies and pharmaceuticals, specifically Activase 100 mg vials, with a delivery order valued at $20,507.10. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of February 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...